Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Haematologica
|
July 1, 1995
A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma
G Lambertenghi Deliliers, C Butti, L Baldini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 14, 2020
Homcology: home chemotherapy delivery in a simultaneous care project for frail advanced cancer patients
C Chini, L Bascialla, A Giaquinto, et al.
Journal of Clinical Pathology
|
July 30, 2009
MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression
S Uccella, R Cerutti, C Placidi, et al.
Leukemia & Lymphoma
|
August 1, 1997
Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma
G Pinotti, E Zucca, E Roggero, et al.
British Journal of Cancer
|
May 6, 1998
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study
E Bajetta, M Di Bartolomeo, C Carnaghi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
L Celio, C N Sternberg, R Labianca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group
E Bajetta, R Buzzoni, L Mariani, et al.
British Journal of Cancer
|
January 25, 2007
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
E Bajetta, M Di Bartolomeo, R Buzzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2000
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)
S Cortelazzo, A Rossi, F Roggero, et al.
Anticancer Research
|
August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study
S Barni, M Visini, E Piazza, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Haematologica
|
July 1, 1995
A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma
G Lambertenghi Deliliers, C Butti, L Baldini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 14, 2020
Homcology: home chemotherapy delivery in a simultaneous care project for frail advanced cancer patients
C Chini, L Bascialla, A Giaquinto, et al.
Journal of Clinical Pathology
|
July 30, 2009
MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression
S Uccella, R Cerutti, C Placidi, et al.
Leukemia & Lymphoma
|
August 1, 1997
Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma
G Pinotti, E Zucca, E Roggero, et al.
British Journal of Cancer
|
May 6, 1998
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study
E Bajetta, M Di Bartolomeo, C Carnaghi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
L Celio, C N Sternberg, R Labianca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2002
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group
E Bajetta, R Buzzoni, L Mariani, et al.
British Journal of Cancer
|
January 25, 2007
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
E Bajetta, M Di Bartolomeo, R Buzzoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2000
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)
S Cortelazzo, A Rossi, F Roggero, et al.
Anticancer Research
|
August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study
S Barni, M Visini, E Piazza, et al.
Page
of 4